Mechanism of uricosuric action of AA-193 in DBA/2N mice.
Six strains of mice were investigated to find an animal model suitable for researching the mechanism of uricosuric agents. A clearance method and a pyrazinamide suppression test were used to examine the mechanism of urate excretion in the kidney and the mode of action of uricosurics, respectively. The negative correlation between the urinary urate excretion and the endogenous plasma urate level was observed, suggesting the net reabsorption of urate may vary between strains. DBA/2N mice showed the lowest fractional excretion of urate (0.278), and the effects of uricosurics on DBA/2N mice are analogous to those of humans. Our extensive study of the mechanism of urate excretion in DBA/2N mice has proven that the mouse strain is a useful model for the study of uricosurics. AA-193 (5-chloro-7,8-dihydro-3-phenylfuro[2,3-g]-1,2-benzisoxazole-7-carb oxylic acid) is a potent new uricosuric agent developed in our laboratory. In the present study, AA-193 was tested in DBA/2N mice and found to have a mode of action different from well-known uricosuric agents. It appeared to inhibit presecretory reabsorption in the proximal tubules.
Dan
T
T
Fuji Gotemba Research Laboratories, Chugai Pharmaceutical, Shizuoka, Japan.
Tanaka
H
H
Koga
H
H
D000818:Animals; D007444:Inulin / Q000378:metabolism; D007555:Isoxazoles / Q000494:pharmacology*; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D010080:Oxazoles / Q000494:pharmacology*; D011718:Pyrazinamide / Q000494:pharmacology; D013045:Species Specificity; D014527:Uric Acid / Q000097:blood / Q000652:urine*; D014528:Uricosuric Agents / Q000494:pharmacology*
D007555:Isoxazoles; D010080:Oxazoles; D014528:Uricosuric Agents; C062919:AA 193; D014527:Uric Acid; D011718:Pyrazinamide; D007444:Inulin